Download Zipped Amended WP 6.1 HB0130.ZIP 14,678 Bytes
[Introduced][Status][Bill Documents][Fiscal Note][Bills Directory]
H.B. 130
1
2
3
4
5
6 Gerry A. Adair
7 Perry Buckner
Gary F. Cox
Bryan D. Holladay
Swen C. Nielsen
8 AN ACT RELATING TO CONTROLLED SUBSTANCES; AMENDING THE CONTROLLED
9 SUBSTANCES PRECURSOR ACT TO ADD CRYSTAL IODINE AS A PRECURSOR;
10 ADDING PROVISIONS TO LIMIT ITS SALE AND POSSESSION TO LEGITIMATE USES;
11 AND LIMITING THE POSSESSION OF SPECIFIED LARGE QUANTITIES OF
12 EPHEDRINE AND PSEUDOEPHEDRINE TO LEGITIMATE USES.
13 This act affects sections of Utah Code Annotated 1953 as follows:
14 AMENDS:
15 58-37c-3, as last amended by Chapter 232, Laws of Utah 1996
16 58-37c-8, as repealed and reenacted by Chapter 155, Laws of Utah 1992
17 ENACTS:
18 58-37c-18, Utah Code Annotated 1953
19 58-37c-19, Utah Code Annotated 1953
20 58-37c-20, Utah Code Annotated 1953
21 Be it enacted by the Legislature of the state of Utah:
22 Section 1. Section 58-37c-3 is amended to read:
23 58-37c-3. Definitions.
24 In addition to the definitions in Section 58-1-102, as used in this chapter:
25 (1) "Board" means the Controlled Substance Precursor Advisory Board created in Section
26 58-37c-4.
27 (2) "Controlled substance precursor" includes a chemical reagent and means any of the
1 following:
2 (a) Phenyl-2-propanone;
3 (b) Methylamine;
4 (c) Ethylamine;
5 (d) D-lysergic acid;
6 (e) Ergotamine and its salts;
7 (f) Diethyl malonate;
8 (g) Malonic acid;
9 (h) Ethyl malonate;
10 (i) Barbituric acid;
11 (j) Piperidine and its salts;
12 (k) N-acetylanthranilic acid and its salts;
13 (l) Pyrrolidine;
14 (m) Phenylacetic acid and its salts;
15 (n) Anthranilic acid and its salts;
16 (o) Morpholine;
17 (p) Ephedrine[
18 (q) Pseudoephedrine[
19 (r) Norpseudoephedrine[
20 (s) Phenylpropanolamine[
21 (t) Benzyl cyanide;
22 (u) Ergonovine and its salts;
23 (v) 3,4-Methylenedioxyphenyl-2-propanone;
24 (w) propionic anhydride;
25 (x) Insosafrole;
26 (y) Safrole;
27 (z) Piperonal;
28 (aa) N-Methylephedrine;
29 (bb) N-ethylephedrine;
30 (cc) N-methylpseudoephedrine;
31 (dd) N-ethylpseudoephedrine;
1 (ee) Hydriotic acid;
2 (ff) any salt, [
3 Subsections (a) through (ee) of this section;
4 (gg) Crystal iodine;
5 [
6 Controlled Substances Act which is designated by the director under the emergency listing
7 provisions set forth in Section 58-37c-14; and
8 [
9 provisions set forth in Section 58-37c-14.
10 (3) "Deliver," "delivery," "transfer," or "furnish" means the actual, constructive, or
11 attempted transfer of a controlled substance precursor.
12 (4) "Matrix" means something, as a substance, in which something else originates,
13 develops, or is contained.
14 [
15 joint venture, corporation, or organization of any type or kind.
16 [
17 pharmacist, scientific investigator, pharmacy, hospital, pharmaceutical manufacturer, or other
18 person licensed, registered, or otherwise permitted to distribute, dispense, conduct research with
19 respect to, administer, or use in teaching, or chemical analysis a controlled substance in the course
20 of professional practice or research in this state.
21 [
22 furnishes, transfers, or otherwise supplies a listed controlled substance precursor chemical in a
23 regulated transaction.
24 (b) "Regulated distributor" does not include any person excluded from regulation under
25 this chapter.
26 [
27 controlled substance precursor chemical in a regulated transaction.
28 (b) "Regulated purchaser" does not include any person excluded from regulation under this
29 chapter.
30 [
31 (a) transfer, distribution, delivery, or furnishing by a person within the state to another
1 person within or outside of the state of a threshold amount of a listed precursor chemical; or
2 (b) purchase or acquisition by any means by a person within the state from another person
3 within or outside the state of a threshold amount of a listed precursor chemical.
4 (10) "Retail distributor" means a grocery store, general merchandise store, drug store, or
5 other entity or person whose activities as a distributor are limited almost exclusively to sales for
6 personal use:
7 (a) in both number of sales and volume of sales; and
8 (b) either directly to walk-in customers or in face-to-face transactions by direct sales.
9 [
10 controlled substance precursor; however, the division may exempt from the provisions of this
11 chapter a specific controlled substance precursor in a specific amount and in certain types of
12 transactions which provisions for exemption shall be defined by the division by rule adopted
13 pursuant to Title 63, Chapter 46a, Utah Administrative Rulemaking Act.
14 [
15 intentionally:
16 (a) engaging in a regulated transaction without first being appropriately licensed or
17 exempted from licensure under this chapter;
18 (b) acting as a regulated distributor and selling, transferring, or in any other way conveying
19 a controlled substance precursor to a person within the state who is not appropriately licensed or
20 exempted from licensure as a regulated purchaser, or selling, transferring, or otherwise conveying
21 a controlled substance precursor to a person outside of the state and failing to report the transaction
22 as required;
23 (c) acting as a regulated purchaser and purchasing or in any other way obtaining a
24 controlled substance precursor from a person within the state who is not a licensed regulated
25 distributor, or purchasing or otherwise obtaining a controlled substance precursor from a person
26 outside of the state and failing to report the transaction as required;
27 (d) engaging in a regulated transaction and failing to submit reports and keep required
28 records of inventories required under the provisions of this chapter or rules adopted pursuant to
29 this chapter;
30 (e) making any false statement in any application for license, in any record to be kept, or
31 on any report submitted as required under this chapter;
1 (f) with the intent of causing the evasion of the recordkeeping or reporting requirements
2 of this chapter and rules related to this chapter, receiving or distributing any listed controlled
3 substance precursor chemical in any manner designed so that the making of records or filing of
4 reports required under this chapter is not required;
5 (g) failing to take immediate steps to comply with licensure, reporting, or recordkeeping
6 requirements of this chapter because of lack of knowledge of those requirements, upon becoming
7 informed of the requirements;
8 (h) presenting false or fraudulent identification where or when receiving or purchasing a
9 listed controlled substance precursor chemical;
10 (i) creating a chemical mixture for the purpose of evading any licensure, reporting or
11 recordkeeping requirement of this chapter or rules related to this chapter, or receiving a chemical
12 mixture created for that purpose;
13 (j) if the person is at least 18 years of age, employing, hiring, using, persuading, inducing,
14 enticing, or coercing another person under 18 years of age to violate any provision of this chapter,
15 or assisting in avoiding detection or apprehension for any violation of this chapter by any federal,
16 state, or local law enforcement official; and
17 (k) obtaining or attempting to obtain or to possess any controlled substance precursor or
18 any combination of controlled substance precursors knowing or having a reasonable cause to
19 believe that the controlled substance precursor is intended to be used in the unlawful manufacture
20 of any controlled substance.
21 [
22 defined by rule includes the following:
23 (a) violation of any provision of this chapter, the Controlled Substance Act of this state
24 or any other state, or the Federal Controlled Substance Act; and
25 (b) refusing to allow agents or representatives of the division or authorized law
26 enforcement personnel to inspect inventories or controlled substance precursors or records or
27 reports relating to purchases and sales or distribution of controlled substance precursors as such
28 records and reports are required under this chapter.
29 Section 2. Section 58-37c-8 is amended to read:
30 58-37c-8. License -- Exceptions from licensure or regulation.
31 (1) Any person engaged in a regulated transaction must be appropriately licensed under
1 [
2 from licensure under [
3 (2) The division shall:
4 (a) establish the form of application for a license, the requirements for licensure, and fees
5 for initial licensure and renewal; and
6 (b) identify required information to be contained in the application as a condition of
7 licensure.
8 (3) A practitioner who holds a Utah Controlled Substance License and a Controlled
9 Substance Registration issued by the Drug Enforcement Administration of the U.S. Government
10 is excepted from licensure under this chapter.
11 (4) Any purchase, sale, transfer, furnishing, or receipt of any drug intended for lawful use
12 in the diagnosis, cure, mitigation, treatment, or prevention of disease in man or other animals,
13 which contains ephedrine, pseudoephedrine, norpseudoephedrine, or phenylpropanolamine if such
14 drug is lawfully purchased, sold, transferred, or furnished as an over-the-counter medication
15 without prescription pursuant to the federal Food, Drug and Cosmetic Act, 21 USC, Sec. 301 et
16 seq., or regulations adopted thereunder are excepted from licensure, reporting, and recordkeeping
17 under this chapter.
18 (5) Any purchase, sale, transfer, receipt, or manufacture of any dietary supplement,
19 vitamins, minerals, herbs, or other similar substances including concentrates or extracts, which are
20 not otherwise [
21 chemicals or substances listed in this chapter, or in rules adopted pursuant to Title 63, Chapter 46a,
22 Utah Administrative Rulemaking Act, are exempt from licensure under this chapter.
23 (6) A purchaser of two ounces or less of crystal iodine in a single transaction is not
24 required to be licensed as a regulated purchaser if the transaction complies with Section 58-37c-18.
25 Section 3. Section 58-37c-18 is enacted to read:
26 58-37c-18. Recordkeeping requirements for sale of crystal iodine.
27 (1) Any person licensed to engage in a regulated transaction and who sells crystal iodine
28 to another person shall:
29 (a) comply with the recordkeeping requirements of Section 58-37-10;
30 (b) require photo identification of the purchaser;
31 (c) obtain from the purchaser a signature on a certificate of identification provided by the
1 seller; and
2 (d) obtain from the purchaser a legible fingerprint, preferably of the right thumb, which
3 shall be placed on the certificate next to the purchaser's signature.
4 (2) Any failure to comply with Subsection (1) is a class B misdemeanor.
5 Section 4. Section 58-37c-19 is enacted to read:
6 58-37c-19. Possession or sale of crystal iodine.
7 (1) Any person licensed to engage in a regulated transaction is guilty of a class B
8 misdemeanor who, under circumstances not amounting to a violation of Subsection
9 58-37d-4(1)(c), offers to sell, sells, or distributes more than two ounces of crystal iodine to another
10 person who is:
11 (a) not licensed as a regulated purchaser of crystal iodine;
12 (b) not excepted from licensure; or
13 (c) not excepted under Subsection (3).
14 (2) Any person who is not licensed to engage in regulated transactions and not excepted
15 from licensure is guilty of a class A misdemeanor who, under circumstances not amounting to a
16 violation of Subsection 58-37c-3(10)(k) or Subsection 58-37d-4(1)(a):
17 (a) possesses more than two ounces of crystal iodine; or
18 (b) offers to sell, sells, or distributes crystal iodine to another.
19 (3) Subsection (2)(a) does not apply to:
20 (a) a chemistry laboratory maintained by:
21 (i) a public or private regularly established secondary school; or
22 (ii) a public or private institution of higher education that is accredited by a regional or
23 national accrediting agency recognized by the United States Department of Education; h [
24 (b) a veterinarian licensed to practice under Title 58, Chapter 28, Veterinarians h [
24a (c) A GENERAL ACUTE HOSPITAL. h
25 Section 5. Section 58-37c-20 is enacted to read:
26 58-37c-20. Possession of ephedrine or pseudoephedrine -- Penalties.
27 (1) Any person S WHO IS NOT LICENSED TO ENGAGE IN REGULATED TRANSACTIONS AND
27a NOT EXCEPTED FROM LICENSURE s who, under circumstances not amounting to a violation of
27b Subsection
28 58-37c-3(10)(k) or Subsection 58-37d-(4)(1)(a), possesses more than 12 grams of ephedrine or
29 pseudoephedrine, their salts, isomers, or salts of isomers, or a combination of any of these
30 substances, is guilty of a class A misdemeanor.
Amend on 2_goldenrod February 26, 1998
31 (2) (a) It is an affirmative defense to a charge under Subsection (1) that the person in
- 7 -
1 possession of ephedrine or pseudoephedrine, or a combination of these two substances:
2 (i) is a physician, pharmacist, retail distributor, wholesaler, manufacturer, warehouseman,
3 or common carrier, or an agent of any of these persons; and
4 (ii) possesses the substances in the regular course of lawful business activities.
5 (b) (i) The defendant shall provide h WRITTEN h notice of intent to claim an affirmative
5a defense under
6 this section as soon as practicable, but not later than ten days prior to trial. The court may waive
7 the notice requirement in the interest of justice for good cause shown, if the prosecutor is not
8 unfairly prejudiced by the lack of timely notice.
9 (ii) The notice shall include the specifics of the asserted defense.
10 (iii) The defendant shall establish the affirmative defense by a preponderance of the
11 evidence. If the defense is established, it is a complete defense to the charges.
12 (3) This section does not apply to dietary supplements, herbs, or other natural products,
13 including concentrates or extracts, which:
14 (a) are not otherwise prohibited by law; and
15 (b) may contain naturally occurring ephedrine, ephedrine alkaloids, or pseudoephedrine,
16 or their salts, isomers, or salts of isomers, or a combination of these substances, that:
17 (i) are contained in a matrix of organic material; and
18 (ii) do not exceed 15% of the total weight of the natural product.
Legislative Review Note
as of 12-19-97 1:25 PM
A limited legal review of this bill raises no obvious constitutional or statutory concerns.
- 8 -
31 (2) (a) It is an affirmative defense to a charge under Subsection (1) that the person in
lilac-February 4, 1998
1 possession of ephedrine or pseudoephedrine, or a combination of these two substances:
2 (i) is a physician, pharmacist, retail distributor, wholesaler, manufacturer, warehouseman,
3 or common carrier, or an agent of any of these persons; and
4 (ii) possesses the substances in the regular course of lawful business activities.
5 (b) (i) The defendant shall provide h WRITTEN h notice of intent to claim an affirmative
5a defense under
6 this section as soon as practicable, but not later than ten days prior to trial. The court may waive
7 the notice requirement in the interest of justice for good cause shown, if the prosecutor is not
8 unfairly prejudiced by the lack of timely notice.
9 (ii) The notice shall include the specifics of the asserted defense.
10 (iii) The defendant shall establish the affirmative defense by a preponderance of the
11 evidence. If the defense is established, it is a complete defense to the charges.
12 (3) This section does not apply to dietary supplements, herbs, or other natural products,
13 including concentrates or extracts, which:
14 (a) are not otherwise prohibited by law; and
15 (b) may contain naturally occurring ephedrine, ephedrine alkaloids, or pseudoephedrine,
16 or their salts, isomers, or salts of isomers, or a combination of these substances, that:
17 (i) are contained in a matrix of organic material; and
18 (ii) do not exceed 15% of the total weight of the natural product.
Legislative Review Note
as of 12-19-97 1:25 PM
A limited legal review of this bill raises no obvious constitutional or statutory concerns.
Office of Legislative Research and General Counsel